Sarah E. Winterton

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
A hallmark of targeted cancer therapies is selective toxicity among cancer cell lines. We evaluated results from a viability screen of over 200,000 small molecules to identify two chemical series, oxalamides and benzothiazoles, that were selectively toxic at low nanomolar concentrations to the same 4 of 12 human lung cancer cell lines. Sensitive cell lines(More)
  • 1